Difference between revisions of "TDRKH-AS1"
Guangyu Wang (talk | contribs) (Created page with "==Annotated Information== ===Approved Symbol=== TDRKH-AS1 ===Approved Name=== TDRKH antisense RNA 1 ===Previous Symbols=== _ ===Synonyms=== RP11-98D18.9 ===Chromosome=== 1q21....") |
Jiabao Cao (talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | |||
==Annotated Information== | ==Annotated Information== | ||
| − | === | + | ===Name=== |
| − | TDRKH-AS1 | + | TDRKH-AS1:TDRKH antisense RNA 1 |
| − | + | ||
| − | TDRKH antisense RNA 1 | + | RP11-98D18.9<ref name="ref1" /> |
| − | = | + | |
| − | + | ===Expression=== | |
| − | === | + | Co-expression analysis of EZH2 in TCGA data and comparison with ChIP sequencing results show that RP11-98D18.9 is positively correlated with EZH2.<ref name="ref1" /> |
| − | RP11-98D18.9 | + | |
| − | == | + | ==Labs working on this lncRNA== |
| − | + | * Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. | |
| − | == | + | ==References== |
| − | + | <references> | |
| − | + | <ref name="ref1"> | |
| − | + | Li Y, Luo M, Shi X, Lu Z, Sun S, Huang J, Chen Z, He J. Integrated | |
| − | + | bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA | |
| − | + | expression by ChIP sequencing and RNA sequencing. Oncotarget. 2016 Dec | |
| − | + | 6;7(49):81715-81726. | |
| − | + | </ref> | |
| + | </references> | ||
Revision as of 02:08, 10 November 2017
Annotated Information
Name
TDRKH-AS1:TDRKH antisense RNA 1
RP11-98D18.9[1]
Expression
Co-expression analysis of EZH2 in TCGA data and comparison with ChIP sequencing results show that RP11-98D18.9 is positively correlated with EZH2.[1]
Labs working on this lncRNA
- Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
